Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Michael J Ray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Clostridium Infections, Anti-Bacterial Agents, Antimicrobial Stewardship, Clostridioides difficile. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Antibiotics are a strong risk factor for Clostridioides difficile infection (CDI), and CDI incidence is often measured as an important outcome metric for antimicrobial stewardship interventions aiming to reduce antibiotic use. However, risk of CDI from antibiotics varies by agent and dependent on the intensity (ie, spectrum and duration) of antibiotic therapy. Thus, the impact of stewardship interventions on CDI incidence is variable, and understanding this risk requires a more granular measure of intensity of therapy than traditionally used measures like days of therapy (DOT).
Methods
We performed a retrospective cohort study to measure the independent association between intensity of antibiotic therapy, as measured by the antibiotic spectrum index (ASI), and hospital-associated CDI (HA-CDI) at a large academic medical center between January 2018 and March 2020. We constructed a marginal Poisson regression model to generate adjusted relative risks for a unit increase in ASI per antibiotic day.
Results
We included 35 457 inpatient encounters in our cohort. Sixty-eight percent of patients received at least 1 antibiotic. We identified 128 HA-CDI cases, which corresponds to an incidence rate of 4.1 cases per 10 000 patient-days. After adjusting for known confounders, each additional unit increase in ASI per antibiotic day was associated with 1.09 times the risk of HA-CDI (relative risk = 1.09; 95% CI: 1.06–1.13).
Conclusions
The ASI was strongly associated with HA-CDI and could be a useful tool in evaluating the impact of antibiotic stewardship on HA-CDI rates, providing more granular information than the more commonly used DOT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA.
- Oregon Health & Science University-Portland State University School of Public Health, Portland, Oregon, USA.
- Division of Infectious Diseases, Oregon Health & Science University School of Medicine, Portland, Oregon, USA.
- Washington State University Allen School for Global Health, Pullman, Washington, USA.
- Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Michael J Ray
Förderung
- NIGMS NIH HHS
- NIH HHS
- NCATS NIH HHS
- Oregon Clinical and Translational Research Institute
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Ray, M. J., Strnad, L. C., Tucker, K. J., Furuno, J. P., Lofgren, E. T., McCracken, C. M., Park, H., Gerber, J. S., & McGregor, J. C. (2024). Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae259
Vancouver
Ray MJ, Strnad LC, Tucker KJ, Furuno JP, Lofgren ET, McCracken CM, et al. Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae259
BibTeX
@article{Ray2024,
author = {Ray, Michael J and Strnad, Luke C and Tucker, Kendall J and Furuno, Jon P and Lofgren, Eric T and McCracken, Caitlin M and Park, Hiro and Gerber, Jeffrey S and McGregor, Jessina C},
title = {Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae259}
}
EUVIMED